Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of Vesatolimod in adults with HIV infection was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vesatolimod (vesatolimod)

Snippet

Sponsor: Gilead Sciences | Conditions: Human Immunodeficiency Virus Type 1 (HIV-1) Infection | Phase 1 | Status: TERMINATED | Results posted: 2024-12-03